ペンシルベニアにおける非筋層浸潤性膀胱癌の臨床試験
ペンシルベニア内の拠点で、非筋層浸潤性膀胱癌に関する9件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- Geisinger Medical Oncology-Lewisburg, Lewisburg
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- MidLantic Urology ( Site 0102), Bala-Cynwyd
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
- University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06919965A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- MidLantic Urology - Haverford Road - Bryn Mawr, Bryn Mawr
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT07309445Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- MidLantic Urology, Cynwyd
被験者募集中第1/2相
18歳〜85歳 · 全性別 · 2026/03/27更新 · NCT06800963ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。